MedPath
NMPA Approval

Adalimumab Solution for Injection

国药准字S20190043

December 6, 2019

Drug Information

阿达木单抗注射液

安健宁

安健宁

注射剂

0.8ml:40mg

生物制品

December 6, 2019

Company Information

Applicant Company

浙江省杭州市富阳区胥口镇海正路8号

Manufacturing Company

浙江省杭州市富阳区胥口镇海正路8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

阿达木单抗注射液 - NMPA 批准文号 | MedPath